rs2100451649

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_022114.4(PRDM16):​c.5G>A​(p.Arg2Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2P) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 29)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PRDM16
NM_022114.4 missense

Scores

5
3
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.64

Publications

0 publications found
Variant links:
Genes affected
PRDM16 (HGNC:14000): (PR/SET domain 16) The reciprocal translocation t(1;3)(p36;q21) occurs in a subset of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). This gene is located near the 1p36.3 breakpoint and has been shown to be specifically expressed in the t(1:3)(p36,q21)-positive MDS/AML. The protein encoded by this gene is a zinc finger transcription factor and contains an N-terminal PR domain. The translocation results in the overexpression of a truncated version of this protein that lacks the PR domain, which may play an important role in the pathogenesis of MDS and AML. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
PRDM16-DT (HGNC:48664): (PRDM16 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3748707).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM16NM_022114.4 linkc.5G>A p.Arg2Gln missense_variant Exon 1 of 17 ENST00000270722.10 NP_071397.3 Q9HAZ2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM16ENST00000270722.10 linkc.5G>A p.Arg2Gln missense_variant Exon 1 of 17 1 NM_022114.4 ENSP00000270722.5 Q9HAZ2-1

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
1419072
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
705294
African (AFR)
AF:
0.00
AC:
0
AN:
30636
American (AMR)
AF:
0.00
AC:
0
AN:
39994
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34850
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81956
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50872
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1091594
Other (OTH)
AF:
0.00
AC:
0
AN:
58408
GnomAD4 genome
Cov.:
29

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Left ventricular noncompaction 8 Uncertain:1
Nov 27, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with PRDM16-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces arginine with glutamine at codon 2 of the PRDM16 protein (p.Arg2Gln). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and glutamine. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.97
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.53
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.012
T;.;.;T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.27
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.87
D;D;D;D
M_CAP
Pathogenic
0.37
D
MetaRNN
Benign
0.37
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.81
.;L;.;L
PhyloP100
5.6
PrimateAI
Pathogenic
0.84
D
PROVEAN
Benign
0.14
N;N;N;N
REVEL
Benign
0.14
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D
Polyphen
0.036, 0.021
.;B;.;B
Vest4
0.37
MutPred
0.22
Loss of methylation at R2 (P = 0.0052);Loss of methylation at R2 (P = 0.0052);Loss of methylation at R2 (P = 0.0052);Loss of methylation at R2 (P = 0.0052);
MVP
0.35
MPC
1.2
ClinPred
0.62
D
GERP RS
1.8
PromoterAI
0.016
Neutral
Varity_R
0.77
gMVP
0.12
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2100451649; hg19: chr1-2985828; API